Physician

Adam Dean Perzin, M.D.

According to 2025 Medicare claims, Adam Perzin, M.D. (NPI: 1104879501) practices urology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 08054-1573. Perzin is affiliated with the AtlantiCare Health Solutions, Inc. (ACO ID: A4516) and Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Perzin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 887 traditional Medicare patients, billed 11,489 HCPCS/CPT codes, and received $441,067 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,885 prescription claims across 726 beneficiaries totaling $2,959,363 in drug costs, led by Xtandi (Enzalutamide). DME data shows 44 claims. Open Payments data shows 4 records totaling $2,571. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $326,914 to $2,959,363. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,331 and ending at $955.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,096	6,932	$521,156
2016	1,096	9,578	$563,810
2017	1,082	11,858	$671,292
2018	1,128	16,122	$883,827
2019	1,004	12,935	$822,429
2020	716	13,700	$579,256
2021	858	18,414	$683,402
2022	890	18,556	$661,807
2023	839	11,106	$435,177
2024	887	11,489	$441,067

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	409	1,863	$326,914
2016	451	2,149	$478,510
2017	549	2,487	$733,040
2018	583	2,520	$1,245,543
2019	588	2,359	$1,662,955
2020	530	2,173	$2,651,908
2021	609	2,265	$2,802,339
2022	637	2,430	$3,337,583
2023	620	2,499	$3,612,981
2024	726	2,885	$2,959,363

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	254	$16,037
2016	N/R	221	$16,070
2017	N/R	160	$13,881
2018	N/R	70	$10,165
2019	N/R	47	$10,092
2020	N/R	22	$7,435
2021	N/R	27	$10,686
2022	N/R	19	$9,225
2023	N/R	82	$14,152
2024	N/R	44	$12,521

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	530	968	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	352	495	$68
51798	Ultrasound measurement of bladder capacity after voiding	420	632	$9
36415	Insertion of needle into vein for collection of blood sample	430	757	$9
81003	Automated urinalysis test	307	456	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	115	3,450	$1,551,318
Erleada	Apalutamide	31	930	$444,071
Abiraterone Acetate	Abiraterone Acetate	190	5,700	$402,814
Nubeqa	Darolutamide	30	900	$356,165
Myrbetriq	Mirabegron	97	7,160	$103,796

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	18	$11,359
A4349	Male external catheter, with or without adhesive, disposable, each	N	N/R	11	$709
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	15	$453

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$38	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$2,533	Sumitomo Pharma America, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Dean Perzin, M.D.?

Tedicare shows public-source Medicare data for Adam Dean Perzin, M.D. (NPI 1104879501), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Dean Perzin, M.D. have ACO affiliation data?

Adam Dean Perzin, M.D. is shown with ACO affiliation data for AtlantiCare Health Solutions, Inc. (MSSP, ACO ID A4516) and Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Adam Dean Perzin, M.D.?

Adam Dean Perzin, M.D. is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Adam Dean Perzin, M.D. have Open Payments data?

Adam Dean Perzin, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.